In the Japan business unit, sales of Lixiana, a direct oral anticoagulant ... mainly due to an increase in sales of genetic injectable drugs and Venofer for iron deficiency anemia treatment.

The resulting ascites was taken 3 days after the last injection using EDTA as anticoagulant to prevent ... as models for screening of antitumor drugs we consider that NK/Ly lymphoma should be also ...

DUBLIN--(BUSINESS WIRE)--The "Anticoagulants Market Global Forecast Report by Drug Class, Route of Administration, Distribution Channel, Application, Countries and Company Analysis 2025-2033 ...

“We found that antiplatelet and anticoagulant medications did not negatively affect the PPV of mt-sDNA testing for advanced colorectal neoplasia,” Garg said. “The mt-sDNA test showed a PPV ...

Opens in a new tab or window Novel agent abelacimab has potential to be a safer anticoagulant ... so the risk of drug-drug interactions is reduced. There is no need to adjust the dose on the ...

On Tuesday, Glenmark Pharmaceuticals announced the launch of Phytonadione injectable emulsion, an anticoagulant, through its US division. According to a release from Glenmark Pharmaceuticals Inc ...

For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor with much lower safety risks compared with a direct oral anticoagulant ...

Use of Anticoagulant Drug After Aortic Valve Replacement Lowers ... 2023 — Patients hospitalized with fractures typically receive an injectable blood thinner, low-molecular-weight heparin ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study.

The safety of abelacimab as compared with a direct oral anticoagulant in patients with ... to receive subcutaneous injection of abelacimab (150 mg or 90 mg once monthly) administered in a blinded ...